Glaxosmithkline Pakistan Limited · PSX:GLAXO
Glaxosmithkline Pakistan — Investor Presentation (December 2025)
17 slides from Glaxosmithkline Pakistan's investor presentation, Dec 5, 2025
Slide 1: Corporate Briefing Session 2025
CORPORATE BRIEFING SESSION 2025
Slide 2: Meeting link and Q&A via Vevox
Meeting link and Q&A via Vevox MS Team Link for https://teams.microsoft.com/meet/21808747253996?p=SPzzcXtOukvxrDV1 Attendees hs Meeting ID: 218 087 472 539 96 Password: JX2Sa79n Posting of Q&As via Login to https://vevox.app/#/m/136729806 Vevox Session ID: 136-729-806 Or scan the QR Code 2
Slide 3: Table of Content
TABLE OF CONTENT • Company Overview • Economic Overview • Financial Outline • Q/A 3
Slide 4: Company Overview
gsk.com Company Overview
Slide 5: Board of Directors
Board of Directors Ms. Lai Kuen Goh Ms. Erum Shakir Rahim Mr. Hasham Ali Baber Ms. Maheen Rahman Mr. Muneer Kamal Mr. Mehmood Ms. Ana Paula De (Chairperson) (Chief Executive Officer) (Chief Financial Officer) (Independent Director) (Independent Director) Mandviwalla Freitas Passos (Non-Executive Dir
Slide 6: We unite science, technology and talent to get ahead of disease together
Our purpose We unite science, technology and talent to get ahead of disease together 05 December 2025 6
Slide 7: How we'll get Ahead Together
How we’ll get Ahead Together Our culture and thriving GSK people Ambitious We’re investing in innovation and growth at pace to achieve for patients health impact at scale Accountable We set focused objectives with for impact clear measures of success Do the right thing We act responsibly and aim to
Slide 8: Our Key Brands
Our Key Brands Augmentin Amoxil Calpol Vates Velosef 8
Slide 9: Top Employer Award
Top Employer Award TOP EMPLOYER 2025 GSK Pakistan has been recognised as a Top Employer in Pakistan Being certified as a Top Employer for five consecutive years reflects GSK Pakistan’s dedication to a better world of work and exhibits this through excellent HR policies and people practices 2025 9
Slide 10: Economic Overview
@ ask.com Economic Overview
Slide 11: Economic Overview
Economic Overview CPI inflation % Monetary Policy Rate % 28.3 22.0 22.0 22.0 22.0 22.0 20.5 19.5 19.5 23.1 17.5 20.7 17.3 12.0 12.0 12.0 12.0 11.0 11.0 11.0 11.0 11.0 11.8 12.6 11.1 9.6 6.9 5.6 3.5 3.2 4.1 3.5 2.4 1.5 0.7 0.3 Jan Feb Mar Apr May Jun Jul Aug Sep Jan Feb Mar Apr May Jun Jul Aug Sep 20
Slide 12: Economic Overview – Contd.
Economic Overview – Contd. KSE – 100 (monthly average) Monthly Exchange Rates 284.4 283.8 165.5 148.6 282.4 139.4 282.0 281.7 125.6 117.8 119.7 280.7 281.0 114.3 113.3 111.3 279.4 280.1 279.3 78.4 77.9 78.5 81.1 278.6 278.8 71.1 75.9 278.5 278.6 278.7 278.7 278.5 64.6 67.0 278.3 62.0 Jan Feb Mar Apr
Slide 13: Financial Outline
Financial Outline @ ask.com
Slide 14: Key Financial Highlights – YTD Sep 2025
Key Financial Highlights – YTD Sep 2025 Net Sales: 45 billion (2024: 44 billion) Gross Margin: 36% (2024: 22%) PBT: 10 billion (2024: 6 billion) EPS: 19.57 (2024: 11.25) 14
Slide 15: Key Financial Highlights – YTD Sep 2025 - Contd.
Key Financial Highlights – YTD Sep 2025 - Contd. Profit After Tax 6.5 bn 6.2 bn 5.4 bn Opex to Sales Ratio 70,000,000 16% 14% 2.5 bn 60,000,000 14% 13% 12% 11% 11% 12% 50,000,000 0.5 bn 10% 40,000,000 2021 2022 2023 20242 YTD Sep 2025 8% 30,000,000 6% 20,000,000 Return on Equity 4% 10,000,000 2% 26%
Slide 16: Key Financial Ratios
Key Financial Ratios Sep 30, Sep 30, Ratios 2025 2024 Return on equity 21% 14% Current Ratio 1.88 1.68 Inventory days 164 125 Receivable days 4 4 Payable days 52 66 16
Slide 17: Questions & Answers
Questions & Answers @ ask.com
GlaxoSmithKline Pakistan — Investor Presentation (December 2025) on 6ix